GRAIL, Inc. Earnings Per Share (Basic)
GRAIL, Inc. (GRAL) reported Earnings Per Share (Basic) of -$2.56 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- GRAIL, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$2.56.
- GRAIL, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$2.29.
- GRAIL, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$2.43.
- GRAIL, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$2.46.
- GRAIL, Inc. earnings per share, basic for fiscal 2025 was -$11.11.
- GRAIL, Inc. earnings per share, basic for fiscal 2024 was -$63.54.
- GRAIL, Inc. earnings per share, basic for fiscal 2023 was -$47.21.
- GRAIL, Inc. earnings per share, basic for fiscal 2023 was -$173.89.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.56 10-Q · filed 2026-08-06 | -$4.86 10-Q · filed 2026-08-06 | -$7.29 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$9.75 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$2.29 10-Q · filed 2026-05-07 | -$4.73 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$7.18 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$10.31 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$2.43 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$4.89 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$8.04 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$11.11 10-K · filed 2026-03-12 |
| 2025-09-30 | -$2.46 10-Q · filed 2025-11-13 | -$5.64 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$8.73 10-Q · filed 2025-11-13 | -$11.62 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$3.18 10-Q · filed 2026-08-06 | -$6.28 10-Q · filed 2026-08-06 | -$9.18 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$13.07 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$3.10 10-Q · filed 2026-05-07 | -$5.98 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$9.89 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$58.51 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2024-12-31 | -$2.89 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$6.80 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$56.18 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$63.54 10-K · filed 2026-03-12 |
| 2024-09-30 | -$3.94 10-Q · filed 2025-11-13 | -$54.38 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$61.61 10-Q · filed 2025-11-13 | -$67.74 derived: net income ÷ weighted average shares · filed 2026-03-12 |
| 2024-06-30 | -$51.06 10-Q · filed 2025-08-13 | -$58.11 10-Q · filed 2025-08-13 | -$64.15 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$92.86 derived: net income ÷ weighted average shares · filed 2026-03-12 |
| 2024-03-31 | -$7.05 10-Q · filed 2025-05-14 | -$13.09 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$41.80 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$48.02 derived: net income ÷ weighted average shares · filed 2026-03-12 |
| 2023-12-31 | -$6.04 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$34.75 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$40.97 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$47.21 10-K · filed 2025-03-05 |
| 2023-10-01 | -$28.71 10-Q · filed 2024-11-13 | -$34.93 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$41.17 10-Q · filed 2024-11-13 | |
| 2023-06-30 | -$6.22 10-Q · filed 2024-08-13 | -$12.45 10-Q · filed 2024-08-13 | ||
| 2023-01-01 | -$173.89 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |